1.Please indicate your specialty.

Cardiology

Endocrinology/Diabetes

Primary Care

Other (please specify)

2.Are you comfortable prescribing SGLT-2 inhibitors or GLP-1 RAs for your patients? 

Yes

No

3.What factors, if any, contribute to your reluctance to prescribe GLP-a RAs and SGLT-2is?

Unknown side-effects.

The prescription of such medications falls outside the scope of my practice.

I am unfamiliar with these drugs.

 I am willing and interested in prescribing these therapies.

4.Who do you think is ultimately responsible for prescribing these agents?

Cardiologists

Endocrinologists

Nephrologists

Primary care physicians

Shared responsibility via collaborative care between various specialists

5.In the appropriate setting, what additional information would increase your likelihood of prescribing these medications?

Supporting information from clinical trials.

An algorithm delineating the population that qualifies for these secondary therapies and the respective dosing.

I would not feel comfortable prescribing these medications.

I already feel comfortable prescribing these medications.